BackGreenLight Biosciences- Warrants (30/09/2027) Overview

GreenLight Biosciences- Warrants (30/09/2027) Current Assets

Latest current assets for GRNAW: $38M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$37.70M
↓ 61.12% YoYΔ $-59.25M vs prior year quarter

Peer trimmed avg / median

Loading

GreenLight Biosciences- Warrants (30/09/2027) Current Assets History

Loading

GreenLight Biosciences- Warrants (30/09/2027) vs. peers: Current Assets Comparison

Loading

GreenLight Biosciences- Warrants (30/09/2027) Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

GreenLight Biosciences- Warrants (30/09/2027) (GRNAW) FAQ

As of the most recent data (March 2023), GRNAW shows a current assets of $38M. That compares with $97M in the prior-year period — down 61.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, GRNAW's current assets is now $38M (was $97M) — a 61.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether GreenLight Biosciences- Warrants (30/09/2027) is outperforming or lagging.

Tracking GRNAW's current assets over time shows whether GreenLight Biosciences- Warrants (30/09/2027) is scaling, shrinking, or reshaping that part of the business. The current reading is $38M That compares with $97M in the prior-year period — down 61.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has GreenLight Biosciences- Warrants (30/09/2027)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $38M) with ownership activity and broader fundamentals.